Clinical Trials Directory

Trials / Completed

CompletedNCT00013962

Vitamin D Metabolism and the Williams Syndrome

Status
Completed
Phase
Study type
Observational
Enrollment
Sponsor
National Center for Research Resources (NCRR) · NIH
Sex
All
Age
18 Years – 50 Years
Healthy volunteers
Accepted

Summary

The Williams syndrome is a disease in which supravalvular aortic stenosis, an elfin facies, mental retardation and other congenital defects are sometimes associated with abnormal vitamin D and calcium metabolism. Whereas some patients have been reported to show increased sensitivity to vitamin D or an exaggerated response of serum 25-hydroxyvitamin D {25(OH)D} to administration of vitamin D and to have hypercalcemia caused by increased circulating 1,25-dihydroxyvitamin D{1,25(OH)2D} in infancy and early childhood, most patients have normal calcium metabolism and normal values for circulating 25(OH)D and 1,25(OH)2D. We propose to carry out further studies of vitamin D metabolism to elucidate the mechanism(s) for abnormal vitamin D metabolism. We will determine the response of serum 1,25(OH)2D to administration of 1,25(OH)2D3. Measurement of the 1,25(OH)2D in the patients compared to normal subjects will be the primary outcome.

Conditions

Interventions

TypeNameDescription
DRUGVitamin D

Timeline

First posted
2001-04-05
Last updated
2005-06-24

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00013962. Inclusion in this directory is not an endorsement.

Vitamin D Metabolism and the Williams Syndrome (NCT00013962) · Clinical Trials Directory